Literature DB >> 23077228

Retinal nerve fibre layer thickness in ARSACS: myelination or hypertrophy?

Elena Garcia-Martin, Luis E Pablo, Jose Gazulla, Vicente Polo, Antonio Ferreras, Jose M Larrosa.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 23077228      PMCID: PMC3582091          DOI: 10.1136/bjophthalmol-2012-302309

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) was first described in the French-Canadian founder population of Quebec in 1978, but genetically confirmed patients have now been reported in individuals from Europe and Japan. Ataxia, dysarthria, spasticity with extensor plantar reflexes, distal muscle wasting, sensorimotor neuropathy and horizontal gaze-evoked nystagmus constitute the most frequent progressive neurological signs. Neuroimaging reveals atrophy of the superior vermis, cervical spinal cord, and cerebral cortex.1 SACS is the most frequent gene associated with ARSACS.2 Previous authors reported that retinal hypermyelinated fibres observed in funduscopy are a minor diagnostic criterion for ARSACS that may identify patients with early-onset cerebellar ataxia and characteristic pontine abnormalities.2 3 We found patients with full ophthalmological examination and retinal nerve-fibre layer (RNFL) photographs showing significant increases in RNFL thickness compared to healthy subjects, but not the myelinated fibres radiating from the optic disk described by previous authors. In addition, digital imaging technologies such as optical coherence tomography to measure peripapillary RNFL thickness and provide retinal images show an increase in the RNFL density in these patients. These findings suggest that RNFL hypertrophy in ARSACS patients was interpreted as hypermyelinated retinal fibres in previous reports, and thus the ARSACS diagnostic criteria, particularly with regard to retinal alterations, should be revised. Increases in RNFL density cause retinal streaks observed in the funduscopy exam that may be confused with hypermyelinated fibres, but the physiopathology, clinical manifestations and optical coherence tomography images and measurements are different (figure 1).4–6
Figure 1

Optical coherence tomography, monochromatic funduscopy images and stereophotographs in left eye from a patient with Spastic Ataxia of Charlevoix-Saguenay (ARSACS), in left eye with hypermyelinated retinal fibres, and in left eye from a healthy subject. The optical coherence tomography of an eye from an ARSACS patient shows a regular increase of retinal nerve fibre layer thickness in all quadrants (yellow arrows). Notice the values of retinal nerve fibre layer thickness (below), uniformly above the green (95% normal range) zone around the nerve optic and the high average thickness (193 microns). Colour funduscopy image of the same patient shows the characteristic telltale yellow discoloration of this disease while the monochromatic photograph (red free procedure) illustrates an increased visibility of the retinal nerve fibre layer. The optical coherence tomography of an eye with Persistent Myelinated Retinal Nerve Fibres shows a localised thickening of the retinal nerve-fibre layer in the temporal superior area (red arrow) while the rest of the layer remains between the normal limits (green area below). The colour and monochromatic funduscopy images of the abovementioned subject with Persistent Myelinated Retinal Nerve Fibres showed that the myelinated nerve fibres are localised in the superior temporal area showing a white-yellowish tone, whereas the rest of the area surrounding the optic disc is normal. The eye of a healthy subject shows no alterations, localised or diffuse thickening, in all tests: optical coherence tomography, colour funduscopy image and monochromatic photograph.

Optical coherence tomography, monochromatic funduscopy images and stereophotographs in left eye from a patient with Spastic Ataxia of Charlevoix-Saguenay (ARSACS), in left eye with hypermyelinated retinal fibres, and in left eye from a healthy subject. The optical coherence tomography of an eye from an ARSACS patient shows a regular increase of retinal nerve fibre layer thickness in all quadrants (yellow arrows). Notice the values of retinal nerve fibre layer thickness (below), uniformly above the green (95% normal range) zone around the nerve optic and the high average thickness (193 microns). Colour funduscopy image of the same patient shows the characteristic telltale yellow discoloration of this disease while the monochromatic photograph (red free procedure) illustrates an increased visibility of the retinal nerve fibre layer. The optical coherence tomography of an eye with Persistent Myelinated Retinal Nerve Fibres shows a localised thickening of the retinal nerve-fibre layer in the temporal superior area (red arrow) while the rest of the layer remains between the normal limits (green area below). The colour and monochromatic funduscopy images of the abovementioned subject with Persistent Myelinated Retinal Nerve Fibres showed that the myelinated nerve fibres are localised in the superior temporal area showing a white-yellowish tone, whereas the rest of the area surrounding the optic disc is normal. The eye of a healthy subject shows no alterations, localised or diffuse thickening, in all tests: optical coherence tomography, colour funduscopy image and monochromatic photograph. The SACS gene is involved in nerve fibre development, so ARSACS patients may tend to have hypermyelinated retinal fibres, but re-evaluation of the published articles that some of the images that were considered to show myelinated fibres radiating from the optic disk by previous authors actually shown an increase in the number of retinal nerve fibres (figure 1). In addition, our hypothesis of RNFL hypertrophy is strengthened by the following findings: tensor diffusion sequences indicate that the hypointense striation corresponds with hyperplasia of the pontocerebellar fibres, which leads to abnormally thick middle cerebellar peduncles;5 6 T2 and T2-fluid attenuation inversion recovery-weighted MRI sequences reveal cerebellar atrophy and a hypointense linear striation at the pons;5 6 ultrastructural observations do not corroborate the notion that hypermyelinated fibres constitute the basic pathophysiology of the retinal abnormities in ARSACS patients;4 genetic studies indicate that SACS functions in nerve fibre development; and nerve biopsies in patients published to date reveal only a depletion of myelinated fibres, and not hypermyelinated fibres (figure 2).4
Figure 2

Examples of previously published funduscopy images from Spastic Ataxia of Charlevoix-Saguenay (ARSACS) patients that probably were mistakenly considered to show hypermyelinated retinal fibres. A complete neuro-ophthalmological examination including stereophotographs, retinal nerve fibre photographs and analysis with digital image analysis devices such as optical coherence tomography in these ARSACS patients may demonstrate that they present increased retinal nerve fibre layer density and thickness instead hypermyelinated retinal fibres.

Examples of previously published funduscopy images from Spastic Ataxia of Charlevoix-Saguenay (ARSACS) patients that probably were mistakenly considered to show hypermyelinated retinal fibres. A complete neuro-ophthalmological examination including stereophotographs, retinal nerve fibre photographs and analysis with digital image analysis devices such as optical coherence tomography in these ARSACS patients may demonstrate that they present increased retinal nerve fibre layer density and thickness instead hypermyelinated retinal fibres. Our results suggest that the retinal streaks are caused by increases in RNFL density, but diagnostic histology of pathological specimens from deceased patients are needed to confirm it. The most recent studies in ARSACS patients suggest a role for the SACS gene in nerve fibre development, causing RNFL hypertrophy and alterations in the central nervous system. In our opinion, some of the fundus images described as showing hypermyelinated retinal fibres are actually showing increased thickness of the RNFL as in our patients2 3 (figure 1). Therefore, we recommend that experts review these published photographs and perform a complete ophthalmological examination based on stereophotographs, RNFL photographs and analysis with digital image analysis devices.
  6 in total

1.  New findings in the ataxia of Charlevoix-Saguenay.

Authors:  José Gazulla; Isabel Benavente; Ana Carmen Vela; Miguel Angel Marín; Luis Emilio Pablo; Alessandra Tessa; María Rosario Barrena; Filippo Maria Santorelli; Claudia Nesti; Pedro Modrego; María Tintoré; José Berciano
Journal:  J Neurol       Date:  2011-10-13       Impact factor: 4.849

2.  Characteristic MRI and funduscopic findings help diagnose ARSACS outside Quebec.

Authors:  M Gerwig; S Krüger; F R Kreuz; S Kreis; E R Gizewski; D Timmann
Journal:  Neurology       Date:  2010-12-07       Impact factor: 9.910

Review 3.  Hereditary ataxia, spastic paraparesis and neuropathy in the French-Canadian population.

Authors:  Nicolas Dupré; Jean-Pierre Bouchard; Bernard Brais; Guy A Rouleau
Journal:  Can J Neurol Sci       Date:  2006-05       Impact factor: 2.104

4.  Is the ataxia of Charlevoix-Saguenay a developmental disease?

Authors:  José Gazulla; Ana Carmen Vela; Miguel Angel Marín; Luis Pablo; Filippo Maria Santorelli; Isabel Benavente; Pedro Modrego; María Tintoré; José Berciano
Journal:  Med Hypotheses       Date:  2011-06-12       Impact factor: 1.538

5.  Myelinated retinal fibers in autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Authors:  E M Vingolo; R Di Fabio; S Salvatore; G Grieco; E Bertini; V Leuzzi; C Nesti; A Filla; A Tessa; F Pierelli; F M Santorelli; C Casali
Journal:  Eur J Neurol       Date:  2011-01-25       Impact factor: 6.089

6.  Retinal nerve fiber hypertrophy in ataxia of Charlevoix-Saguenay patients.

Authors:  Luis E Pablo; Elena Garcia-Martin; Jose Gazulla; Jose M Larrosa; Antonio Ferreras; Filippo M Santorelli; Isabel Benavente; Ana Vela; Miguel A Marin
Journal:  Mol Vis       Date:  2011-07-13       Impact factor: 2.367

  6 in total
  6 in total

1.  Sacs knockout mice present pathophysiological defects underlying autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Authors:  Roxanne Larivière; Rébecca Gaudet; Benoit J Gentil; Martine Girard; Talita Cristiane Conte; Sandra Minotti; Kim Leclerc-Desaulniers; Kalle Gehring; R Anne McKinney; Eric A Shoubridge; Peter S McPherson; Heather D Durham; Bernard Brais
Journal:  Hum Mol Genet       Date:  2014-09-26       Impact factor: 6.150

Review 2.  Ophthalmic manifestations of inherited neurodegenerative disorders.

Authors:  Hannah M Kersten; Richard H Roxburgh; Helen V Danesh-Meyer
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

3.  Clinical and molecular studies in two new cases of ARSACS.

Authors:  Ivana Ricca; Federica Morani; Giacomo Maria Bacci; Claudia Nesti; Roberto Caputo; Alessandra Tessa; Filippo Maria Santorelli
Journal:  Neurogenetics       Date:  2019-01-24       Impact factor: 2.660

4.  Absent Foveal Avascular Zone in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.

Authors:  Vivian Paraskevi Douglas; Konstantinos A A Douglas; John B Miller; Eric D Gaier
Journal:  J Neuroophthalmol       Date:  2021-06-01       Impact factor: 3.042

5.  Abnormal retinal thickening is a common feature among patients with ARSACS-related phenotypes.

Authors:  Patrick Yu-Wai-Man; Angela Pyle; Helen Griffin; Mauro Santibanez-Korev; Rita Horvath; Patrick F Chinnery
Journal:  Br J Ophthalmol       Date:  2014-01-23       Impact factor: 4.638

6.  Inner Retinal Dysfunction in the Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.

Authors:  François-Xavier Borruat; Graham E Holder; Fion Bremner
Journal:  Front Neurol       Date:  2017-10-12       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.